alglucosidase alfa (Myozyme, Lumizyme)
Jump to navigation
Jump to search
Indications
- treatment of glycogen storage disease type-2 (Pompe disease)
Dosage
- Dosage:
- 20 mg/kg IV infusion every 2 weeks
Monitor
- liver function tests baseline & periodically[2]
Mechanism of action
More general terms
References
- ↑ UniProt http://www.uniprot.org/uniprot/P10253.html
- ↑ 2.0 2.1 Prescriber's Letter 17(7): 2010 Recommended Lab Monitoring for Common Medications Liver Function Test Scheduling Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=260704&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ HIGHLIGHTS OF PRESCRIBING INFORMATION LUMIZYME (alglucosidase alfa). for injection, for intravenous use https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/125291lbl.pdf